Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: From nanoscale analysis to clinical application
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 162, 112250
Abstract
No abstract availableKeywords
Funding Information
- AbbVie
- Acerta
- Janssen
- Merck
- Merrimack
- Novartis
- OmniSeq
- Pfizer
- PGDx
- Exelixis
- Genentech
- Roche
- Sanofi Aventis
- Genomic Health
- AstraZeneca
- Bristol-Myers Squibb
- Foundation Medicine
- Janssen
- Pfizer
- Pharmacyclics
- Amgen
- Sanofi Aventis
- Capio Biosciences
- Wisconsin Head & Neck Cancer SPORE
- Capio Biosciences, Inc
This publication has 42 references indexed in Scilit:
- Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell LinePLOS ONE, 2013
- Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?Journal of Translational Medicine, 2013
- Carbonic anhydrase IX is a clinically significant tissue and serum biomarker associated with renal cell carcinomaOncology Letters, 2012
- Dendrimer‐Mediated Multivalent Binding for the Enhanced Capture of Tumor CellsAngewandte Chemie International Edition, 2011
- Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasionJournal of Cell Science, 2011
- Circulating Tumor Cells as a Window on Metastasis Biology in Lung CancerThe American Journal of Pathology, 2011
- Carbonic anhydrase 9 in clear cell renal cell carcinoma: A marker for diagnosis, prognosis and treatmentEuropean Journal of Cancer, 2010
- Enhanced Tumor Cell Isolation by a Biomimetic Combination of E-selectin and anti-EpCAM: Implications for the Effective Separation of Circulating Tumor Cells (CTCs)Langmuir, 2010
- Metastasis: from dissemination to organ-specific colonizationNature Reviews Cancer, 2009
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005